F9H-22580-32845
5 vaccinations
5 coded responses
34 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 756 / TX
- Registered
- 2021-02-15
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-14
Dose 1 — Pfizer-BioNTech
-
2021-02-15
Registered in v-safe
-
2021-02-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Swelling · Muscle or body achesAdult check-in
-
2021-02-17
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy, Pain, Pyrexia, Self-medication — Feeling: Good · Site: Pain · Muscle or body achesFree text: Lymph node swelling, on day 2 my armpit was distended. I had to use several ice packs throughout the day and take a pain reliever, Tylenol 3 to bring down the developing fever and ease the pain.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Survey response — days 1–6 daily, dose 1MedDRA: Hypersensitivity — Feeling: Good · Site: Itching · Muscle or body achesFree text: Histamine reactionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-19
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Good · Site: Swelling · Muscle or body achesFree text: This vaccination was given to a me, a person who was previously infected with COVID19 in October 2020. (b)(6)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-20
- 2021-02-21
- 2021-02-28
-
2021-03-06
Dose 2 — Pfizer-BioNTech
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-22
- 2021-03-29
- 2021-04-03
- 2021-04-10
- 2021-04-17
- 2021-06-05
- 2021-09-04
-
2021-10-22
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-03-08
-
2022-04-22
Survey response — 6 months, dose 3MedDRA: Lethargy — Feeling: FairFree text: LethargyMedDRA releases: 2024-11 · check-in free text available
-
2022-05-06
Dose 4 — Pfizer-BioNTech
-
2022-05-15
Survey response — day 7, dose 4MedDRA: Fatigue, Headache, Pyrexia, Temperature intolerance — Feeling: GoodFree text: When in high heat environment my tolerance lowered as compared previously.During the intolerance i got a servers headache despite being hydrated and rested. I was feverish the a day after the injection and exhausted for two days after.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-20
- 2022-05-27
- 2022-06-03
- 2022-06-11
- 2022-06-17
- 2022-08-05
- 2022-11-07
-
2022-12-22
Dose 5 — Pfizer-BioNTechCo-administered: Flu
- 2023-05-07
- 2023-06-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-14 | Pfizer-BioNTech | |
| 2 | 2021-03-06 | Pfizer-BioNTech | |
| 3 | 2021-10-22 | Pfizer-BioNTech | Flu |
| 4 | 2022-05-06 | Pfizer-BioNTech | No |
| 5 | 2022-12-22 | Pfizer-BioNTech | Flu |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Lymph node swelling, on day 2 my armpit was distended. I had to use several ice packs throughout the day and take a pain reliever, Tylenol 3 to bring down the developing fever and ease the pain.
Systemic reaction (other): Histamine reaction
Systemic reaction (other): This vaccination was given to a me, a person who was previously infected with COVID19 in October 2020. (b)(6)
redacted (b)(6)
Release 11 — 6 months, dose 3
Symptoms: Lethargy
Release 11 — day 7, dose 4
Systemic reaction (other): When in high heat environment my tolerance lowered as compared previously.During the intolerance i got a servers headache despite being hydrated and rested. I was feverish the a day after the injection and exhausted for two days after.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Lethargy | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Hypersensitivity | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
| SRO | Temperature intolerance | · | · | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release